Clinical Trials Directory

Trials / Unknown

UnknownNCT04519554

Hysteroscopic Guided Endometrial Sampling: Prospective Comparison Between 5Fr and 7Fr Biopsy Forceps (HYSTEROBIO)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
146 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Indication for hysteroscopic guided biopsy compared to blind biopsy have been little evaluated. However, this kind of biopsy is usually performed in many centre. They allow exploration of uterine cavity but also to perform guided biopsies on the most suspicious area. However, with 5Fr forceps, biopsy are often too small to conclude.

Detailed description

Blind biopsies using Novak or Cormier cannula had limits. Demirkiran et al conclude on 673 women that histology was similar between biopsies and hysterectomy in only 67% of cases. Others studies conclude thatit is difficult to conclude about focal disease with blind biopsies. A study compared blind biopsies to biopsy performed under hysteroscopic guidance in women using Tamoxifene and conclude that guided biopsies were more specific (80% versus 68.9%) and a better positive predictive value (68.9% versus 43.7%) for all kind of endometrial pathologies

Conditions

Interventions

TypeNameDescription
DEVICEEndometrial samplingEndometrial sampling with 2 different forceps

Timeline

Start date
2020-09-20
Primary completion
2021-12-20
Completion
2021-12-20
First posted
2020-08-19
Last updated
2020-09-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04519554. Inclusion in this directory is not an endorsement.